Compare OBT & CGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OBT | CGC |
|---|---|---|
| Founded | 1892 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Major Banks | Pharmaceuticals and Biotechnology |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 457.5M | 401.0M |
| IPO Year | 2021 | 2023 |
| Metric | OBT | CGC |
|---|---|---|
| Price | $38.34 | $0.96 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | ★ $36.00 | N/A |
| AVG Volume (30 Days) | 52.2K | ★ 2.1M |
| Earning Date | 04-28-2026 | 05-29-2026 |
| Dividend Yield | ★ 2.12% | N/A |
| EPS Growth | 34.82 | ★ 84.17 |
| EPS | ★ 0.85 | N/A |
| Revenue | N/A | ★ $12,759,000.00 |
| Revenue This Year | $14.27 | $8.27 |
| Revenue Next Year | $7.99 | $15.68 |
| P/E Ratio | $45.42 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $23.25 | $0.84 |
| 52 Week High | $40.10 | $2.38 |
| Indicator | OBT | CGC |
|---|---|---|
| Relative Strength Index (RSI) | 56.89 | 53.60 |
| Support Level | $35.90 | $0.91 |
| Resistance Level | $38.53 | $1.08 |
| Average True Range (ATR) | 1.03 | 0.04 |
| MACD | -0.02 | 0.01 |
| Stochastic Oscillator | 74.17 | 61.16 |
Orange County Bancorp Inc is a community bank holding company providing commercial and consumer banking services to individuals, small businesses, and local governments. It operates through two segments: Banking and Wealth Management. The Banking segment, the primary revenue driver, offers loans such as commercial real estate, construction, commercial & industrial, multifamily, and residential mortgages, along with services like cash management, escrow, deposits, ATMs, and digital banking. The Wealth Management segment provides investment management, trust services (trustee, administrator, custodian), and financial planning and advisory services to individuals and institutions.
Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.